Valeant Pharmaceuticals To Present At The J.P. Morgan 2015 Healthcare Conference

January 06, 2015

LAVAL, Quebec, Jan. 6, 2015 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced that members of its senior management team will make a presentation at the J.P. Morgan 2015 Healthcare Conference on Tuesday, January 13, 2015 at 7:30am PT

A live webcast and audio archive of the presentations will be available on the company's Web site at www.valeant.com. Click on Investor Relations, and then the link to Events and Presentations. Participants should allow approximately five to ten minutes prior to the presentation's start time to visit the site and download any streaming media software needed to listen to the Internet webcast.

About Valeant Pharmaceuticals International, Inc.

Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, eye health, neurology, and branded generics.  More information about Valeant Pharmaceuticals International, Inc. can be found at www.valeant.com.

Contact Information:
Laurie W. Little
949-461-6002 
laurie.little@valeant.com

Valeant Pharmaceuticals International, Inc.

Logo - http://photos.prnewswire.com/prnh/20101025/LA87217LOGO

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/valeant-pharmaceuticals-to-present-at-the-jp-morgan-2015-healthcare-conference-300016432.html

SOURCE Valeant Pharmaceuticals International, Inc.

Annual Report

2015 Annual Report

The right products
The right philosophy.
record organic growth.

View All